Wednesday, January 14, 2009

Good Interaction between Cancer Research and Transplantation

However, Yesterday We have a big mulled wine party, now, im ready to share with you an intresting news in the light of:

"can it happen ? good side effect of a cancer-medicine" theme.


And yes, i hope mulled wine can eliminate malignant cells too.

Transplantation and bortezomib



According to the Transplantation expert magazine, We are luckily living in our Globus, which has a "bortezomib" concoction with positiv side effect for those who previously were operated with transplantation.

New vaccine, decreasing antibody



This new vaccine was tested by six people, where kidneys were rejected their bodies. But with the usage of this vaccine experten and physicians could ward the rejection process off, and at last, it stopped. Every time they used this product, the rejection-process stopped, and they could successfully decrease the antibody production.

The fact that, this way could be a better than ever in the treatment of transplantation and autoimmune diseases.

A couple years before, bortezomib considerably contributed to the treatment of myeloma multiplex. This concoction is a so-called: proteasoma-inhibitor.

How does it works?

There are cells, and in these cells we can find materials we wanted to be demolished. Well, at first, these have to face with ubikvitin proteinpack. Just like an deadly kiss, namely, after this romantic affair, the protein is willing to walk into one of those incinerator (proteasoma) which are existing that place. And than, it will be demolished by ensimcomplexes.

Bortezomib can block proteasomes in malignant cells.

Good way,

My way, or the highway - singing Fred Durst, it's just a question.